FdaApplication
ANDA 213550
Identifiers
- fda_app_no: ANDA213550
Properties
| Property | Value |
|---|---|
| applicant_name | REGCON HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2022-07-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | 5MG | TABLET;ORAL |
1 product